COVID-19 Vaccines and the Menstrual Cycle

Menstrual Irregularity Clinical Trial

Official title:

COVID-19 Vaccines and the Menstrual Cycle; a Cross-sectional Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05688995
• Other study ID #: ju
• Status: Completed
• Start date: September 30, 2021
• Est. completion date: January 1, 2023

Study information

• Verified date: January 2023
• Source: University of Jordan
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The study aimed to explore the effect of different COVID-19 vaccines on menstrual cycle

Description:

This is a descriptive cross-sectional study that took place between September 2021 and December 2021. The study aimed to explore the effect of different COVID-19 vaccines on menstrual cycle. It used an anonymous questionnaire distributed via social media platforms; Facebook, Twitter, and WhatsApp across different cities of Jordan. A total of 732 responses were received with a 59% response rate. The questionnaire was distributed over four months directed at women who have received at least one dose of the COVID-19 vaccine and who live in Jordan. It took 10 minutes to complete all the questions. Data collection did not involve direct contact with participants to prevent the spread of COVID-19.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 617
• Est. completion date: January 1, 2023
• Est. primary completion date: December 30, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• 18 years and older
• less than 40 years
• healthy women
• received covid-19 vaccine

Exclusion Criteria:

• women who did not receive the vaccine
• those living outside Jordan (those cannot fill the form) and during analysis.

Related Conditions & MeSH terms

• Menstrual Irregularity
• Menstruation Disturbances

Intervention

Biological:
• Naser Al-Husban
COVID-19 vaccines

Locations

Country	Name	City	State
Jordan	Jordan University Hospital	Amman

Sponsors (1)

Lead Sponsor	Collaborator
University of Jordan

Country where clinical trial is conducted

Jordan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	significant changes in the menstrual cycle after vaccination	changes that involve bleeding amount or pain	6 months